1.94
前日終値:
$1.91
開ける:
$1.93
24時間の取引高:
1.06M
Relative Volume:
0.83
時価総額:
$122.62M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.2278
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
+14.12%
1か月 パフォーマンス:
+18.29%
6か月 パフォーマンス:
-16.38%
1年 パフォーマンス:
-41.57%
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MGNX
Macrogenics Inc
|
1.94 | 109.98M | 139.77M | -97.62M | -61.71M | -1.58 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-05-10 | ダウングレード | Stifel | Buy → Hold |
2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
2024-04-26 | 開始されました | B. Riley Securities | Buy |
2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
2024-03-04 | 繰り返されました | BTIG Research | Buy |
2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
2022-02-04 | 開始されました | SMBC Nikko | Outperform |
2021-11-17 | 再開されました | Guggenheim | Buy |
2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
2021-10-15 | 再開されました | BTIG Research | Buy |
2021-04-26 | 再開されました | Credit Suisse | Outperform |
2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
2020-12-22 | 再開されました | H.C. Wainwright | Buy |
2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-04 | 開始されました | Barclays | Underweight |
2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-11-20 | 再開されました | Guggenheim | Neutral |
2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
2019-04-12 | 開始されました | Guggenheim | Neutral |
2019-02-07 | アップグレード | Citigroup | Sell → Buy |
2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
2018-09-10 | 再開されました | BTIG Research | Buy |
2018-05-31 | 開始されました | Evercore ISI | Outperform |
2018-03-05 | 開始されました | H.C. Wainwright | Buy |
2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
Key metrics from MacroGenics Inc.’s quarterly dataPortfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Measuring MacroGenics Inc.’s beta against major indicesJuly 2025 Gainers & Verified Technical Signals - Newser
Using Ichimoku Cloud for MacroGenics Inc. technicalsPortfolio Return Report & Growth-Oriented Investment Plans - Newser
Strategies to average down on MacroGenics Inc.July 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Is MacroGenics Inc. forming a bottoming base2025 Market Trends & Low Drawdown Investment Ideas - Newser
Can MacroGenics Inc. stock double in the next yearJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com
Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
News impact scoring models applied to MacroGenics Inc.Weekly Trend Recap & Low Risk Entry Point Guides - Newser
How to build a dashboard for MacroGenics Inc. stockGap Up & Stepwise Entry and Exit Trade Signals - Newser
Can MacroGenics Inc. reach all time highs this yearWeekly Trade Analysis & Smart Investment Allocation Insights - khodrobank.com
Will MacroGenics Inc. benefit from macro trendsTrade Risk Assessment & Daily Volume Surge Signals - Newser
What to do if you’re stuck in MacroGenics Inc.Rate Hike & AI Driven Stock Reports - Newser
How to interpret RSI for MacroGenics Inc. stockInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Can MacroGenics Inc. recover in the next quarterMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Trend analysis for MacroGenics Inc. this week2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Pattern recognition hints at MacroGenics Inc. upsideBear Alert & Expert Curated Trade Setups - Newser
Trend Report: Can MacroGenics Inc. stock double in the next yearTrade Entry Summary & High Return Trade Guides - khodrobank.com
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
How liquid is MacroGenics Inc. stockJuly 2025 Movers & AI Powered Trade Plan Recommendations - khodrobank.com
Institutional scanner results for MacroGenics Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
What is MacroGenics Inc. s 5 year growth outlookQuarterly Market Summary & Expert Approved Momentum Trade Ideas - khodrobank.com
How to track smart money flows in MacroGenics Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Smart tools for monitoring MacroGenics Inc.’s price action2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Is MacroGenics Inc. stock heavily shortedJuly 2025 PreEarnings & Technical Entry and Exit Tips - khodrobank.com
Applying Elliott Wave Theory to MacroGenics Inc.2025 Technical Overview & Technical Pattern Alert System - Newser
Using fundamentals and technicals on MacroGenics Inc.2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Is MacroGenics Inc. exposed to political riskFed Meeting & Verified Momentum Stock Watchlist - khodrobank.com
Will MacroGenics Inc. benefit from AI trends2025 Buyback Activity & Expert Curated Trade Setups - khodrobank.com
Technical Charts Suggest Momentum Shift in MacroGenics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Long term hold vs stop loss in MacroGenics Inc.2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can MacroGenics Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - 클래시안
Chart based exit strategy for MacroGenics Inc.Quarterly Growth Report & Safe Investment Capital Preservation Plans - Newser
Published on: 2025-08-31 08:28:48 - Newser
How to build a custom watchlist for MacroGenics Inc.Earnings Recap Summary & Consistent Return Investment Signals - Newser
Analyzing net buyer seller activity in MacroGenics Inc.Trade Risk Report & Low Risk High Reward Ideas - Newser
Is MacroGenics Inc. stock reversal real or fakeJuly 2025 Outlook & Short-Term Trading Alerts - Newser
Published on: 2025-08-30 21:45:29 - Newser
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
Macrogenics Inc (MGNX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
HEIDEN WILLIAM K | Director |
Aug 20 '25 |
Buy |
1.49 |
49,500 |
73,755 |
111,000 |
Koenig Scott | Director |
Aug 13 '25 |
Option Exercise |
0.00 |
52,829 |
0 |
830,244 |
Bonvini Ezio | Sr VP, Research & CSO |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
124,414 |
Karrels James | SVP, CFO and Secretary |
Feb 15 '25 |
Option Exercise |
0.00 |
14,998 |
0 |
192,591 |
Koenig Scott | President and CEO |
Feb 15 '25 |
Option Exercise |
0.00 |
42,329 |
0 |
777,415 |
Peters Jeffrey Stuart | Senior VP and General Counsel |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
18,858 |
Risser Eric Blasius | Chief Operating Officer |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
62,422 |
Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Option Exercise |
0.00 |
1,095 |
0 |
9,955 |
Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Sale |
2.56 |
423 |
1,083 |
9,532 |
Spitznagel Thomas | Sr VP, Technical Ops |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
26,922 |
大文字化:
|
ボリューム (24 時間):